| dbo:abstract
|
- حملة التلقيح ضد كوفيد-19 في الولايات المتحدة، حملة تلقيح شاملة مستمرة للاستجابة لوباء كوفيد-19 في الولايات المتحدة. بعد موافقة إدارة الغذاء والدواء على لقاح فايزر-بيونتيك في 10 ديسمبر 2020، بدأ التلقيح الشامل في 14 ديسمبر 2020. جرت الموافقة لاحقًا على استخدام لقاح موديرنا في 17 ديسمبر 2020، ولقاح جونسون آند جونسون في 27 فبراير 2021. بدأت الحملة من قبل حكومة الولايات المتحدة برئاسة دونالد ترامب، وانتقلت إلى جو بايدن، الذي أصبح الرئيس الجديد للولايات المتحدة في 20 يناير 2021. بدأ فترة ولايته بهدف فوري بلغ مئة مليون إبرة لقاح في أول مئة يوم له في منصبه، إذ وقع أمرًا تنفيذيًا تضمن زيادة إمدادات التلقيح. حُقق هذا الهدف في 19 مارس 2021. في 25 مارس 2021، أعلن الرئيس جو بايدن أنه سيضع هدفًا جديدًا للقاح كوفيد-19 يتمثل في إعطاء مئتي مليون إبرة خلال أول 100 يوم له في منصبه. (ar)
- The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later. The Moderna vaccine was granted emergency use authorization on December 17, 2020, and the Janssen (Johnson & Johnson) vaccine was granted emergency use authorization on February 27, 2021. By April 19, 2021, all U.S. states had opened vaccine eligibility to residents aged 16 and over. On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals aged 16 and over. The U.S. government first began the campaign under the presidency of Donald Trump with Operation Warp Speed, a public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January 20, 2021. Biden began his term with an immediate goal of administering 100 million vaccine doses within his first hundred days in office, signing an executive order which included increasing supplies for vaccination. This goal was met on March 19, 2021. On March 25, 2021, he announced he would increase the goal to 200 million within his first 100 days in office. This goal was eventually reached on April 21, 2021. By July 4, 2021, 67% of the United States' adult population had received at least one dose, just short of a goal of 70%. This goal was eventually met on August 2, 2021. While vaccines have helped significantly reduce the number of new COVID-19 infections nationwide, states with below-average vaccination rates began to see increasing numbers of cases credited to the highly infectious Delta variant by July 2021, which led to an increased push by organizations and companies to begin imposing de facto mandates for their employees be vaccinated for COVID-19. On September 9, 2021, President Biden announced plans by the federal government to use executive orders and emergency temporary standards enforced by OSHA to mandate the vaccination of all federal branch employees, and require that all companies with more than 100 employees regularly test all employees who are not yet fully vaccinated for COVID-19. On January 26, 2022, OSHA completely withdrew the vaccine mandate for companies with more than 100 employees due to a ruling from the Supreme Court of the United States that blocked the mandate. As of March 2022, according to The Commonwealth Fund, COVID-19 vaccination in the United States has prevented an additional 2.3 million deaths, an additional 17 million hospitalizations, and an additional 66.2 million infections from COVID-19. Vaccination has also prevented an additional $899.4 billion in healthcare costs. According to a June 2022 study published in The Lancet, COVID-19 vaccination in the United States prevented an additional 1.9 million deaths from December 8, 2020, to December 8, 2021. According to a July 2022 study published in JAMA Network Open, COVID-19 vaccination in the United States prevented an additional 235,000 deaths, an additional 1.6 million hospitalizations, and an additional 27 million infections from December 1, 2020, to September 30, 2021. (en)
- La campaña de vacunación contra COVID-19 en los Estados Unidos es la campaña de inmunización masiva en curso que fue iniciada por el gobierno estadounidense bajo la presidencia de Donald Trump para responder a la pandemia de COVID-19 en los Estados Unidos. Comenzó el 14 de diciembre de 2020, con el objetivo de tener la vacuna ampliamente disponible para el público en mayo de 2021. Joe Biden se convirtió en el nuevo presidente en enero de 2021 y comenzó su mandato con una meta inmediata de 100 millones de inyecciones en sus primeros 100 días. En el cargo, firmando una orden ejecutiva que incluía aumentar los suministros para la vacunación. (es)
- 미국의 코로나19 예방접종은 코로나19 범유행에 대응하기 위한 미국에서의 코로나19 예방접종 프로그램이다. (ko)
- 美國的2019冠狀病毒病疫苗接種計劃，是一項由美国疾病控制与预防中心推行的大規模疫苗接種計劃，旨在通過為所有合資格美國及「自由聯合協定」參與國居民注射2019冠狀病毒病疫苗，以達致對2019冠狀病毒病產生群體免疫。目前，此接種計劃分別採用輝瑞－BioNTech 2019冠狀病毒病疫苗、莫德纳2019冠状病毒病疫苗（均為RNA疫苗，需要接種兩次），以及強生2019冠狀病毒病疫苗（腺病毒載體疫苗，僅需接種一次）。此計劃已於2020年12月14日開始；截至2021年5月15日，已有156,217,367名美國居民已接種最少一劑疫苗，並有121,768,268人已經完成接種。截至2021年7月25日，全美接种至少一剂新冠疫苗的人数约1.88亿，占总人口的56.8%；完成疫苗接种的人数约1.63亿，占总人口的49.1%。截至2021年8月2日，70%的美國成年人已至少接種了1劑新冠疫苗。 (zh)
|
| dbp:label
|
- Johnson & Johnson (en)
- Moderna (en)
- Population who are fully vaccinated, but haven't received an additional booster shot: 115,364,980 (en)
- Population who are fully vaccinated and received an additional booster shot: 85,212,292 (en)
- Population who are fully vaccinated and received two additional booster shots: 25,623,483 (en)
- Not Identified (en)
- Novavax (en)
- Pfizer–BioNTech (en)
- Unvaccinated population: ~66.8 million people (en)
- Population who have received only one dose of a two-dose vaccine: 38,910,734 (en)
|
| rdfs:comment
|
- La campaña de vacunación contra COVID-19 en los Estados Unidos es la campaña de inmunización masiva en curso que fue iniciada por el gobierno estadounidense bajo la presidencia de Donald Trump para responder a la pandemia de COVID-19 en los Estados Unidos. Comenzó el 14 de diciembre de 2020, con el objetivo de tener la vacuna ampliamente disponible para el público en mayo de 2021. Joe Biden se convirtió en el nuevo presidente en enero de 2021 y comenzó su mandato con una meta inmediata de 100 millones de inyecciones en sus primeros 100 días. En el cargo, firmando una orden ejecutiva que incluía aumentar los suministros para la vacunación. (es)
- 미국의 코로나19 예방접종은 코로나19 범유행에 대응하기 위한 미국에서의 코로나19 예방접종 프로그램이다. (ko)
- 美國的2019冠狀病毒病疫苗接種計劃，是一項由美国疾病控制与预防中心推行的大規模疫苗接種計劃，旨在通過為所有合資格美國及「自由聯合協定」參與國居民注射2019冠狀病毒病疫苗，以達致對2019冠狀病毒病產生群體免疫。目前，此接種計劃分別採用輝瑞－BioNTech 2019冠狀病毒病疫苗、莫德纳2019冠状病毒病疫苗（均為RNA疫苗，需要接種兩次），以及強生2019冠狀病毒病疫苗（腺病毒載體疫苗，僅需接種一次）。此計劃已於2020年12月14日開始；截至2021年5月15日，已有156,217,367名美國居民已接種最少一劑疫苗，並有121,768,268人已經完成接種。截至2021年7月25日，全美接种至少一剂新冠疫苗的人数约1.88亿，占总人口的56.8%；完成疫苗接种的人数约1.63亿，占总人口的49.1%。截至2021年8月2日，70%的美國成年人已至少接種了1劑新冠疫苗。 (zh)
- حملة التلقيح ضد كوفيد-19 في الولايات المتحدة، حملة تلقيح شاملة مستمرة للاستجابة لوباء كوفيد-19 في الولايات المتحدة. بعد موافقة إدارة الغذاء والدواء على لقاح فايزر-بيونتيك في 10 ديسمبر 2020، بدأ التلقيح الشامل في 14 ديسمبر 2020. جرت الموافقة لاحقًا على استخدام لقاح موديرنا في 17 ديسمبر 2020، ولقاح جونسون آند جونسون في 27 فبراير 2021. (ar)
- The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later. The Moderna vaccine was granted emergency use authorization on December 17, 2020, and the Janssen (Johnson & Johnson) vaccine was granted emergency use authorization on February 27, 2021. By April 19, 2021, all U.S. states had opened vaccine eligibility to residents aged 16 and over. On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals ag (en)
|
_B.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
_B.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
